News
Under Dr. Geary's leadership, Ionis submitted over 50 investigational new drug applications to regulatory agencies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback